Antony J. Blinken, Secretary of State
Thomas Jefferson Room
SECRETARY BLINKEN: Well, good afternoon, everyone. It’s a pleasure to have Foreign Minister Momen here and to be able to work together on strengthening more the partnership between the United States and Bangladesh. We are in fact celebrating 50 years of diplomatic relations. And even as we think back on those 50 years, we’re really looking ahead to the start of the next 50 and the work that we can do together, as I said, to strengthen our partnership.
Bangladesh has been a leader in rallying other countries to deal with the climate crisis that the planet is facing. We deeply appreciate that, and we’re working closely together as well on COVID-19, and we’re proud to have been able to contribute through COVAX some 61 million vaccine doses to Bangladesh.
In turn, Bangladesh of course is showing extraordinary humanity and generosity in hosting nearly 1 million Rohingya who have had to flee persecution in Burma. We’re grateful for that, and the work that you’ve done as one of the strongest supporters of UN peacekeeping around the world, and many other things as well. But we’ll have an opportunity today to discuss the work we’re doing together bilaterally in the region and indeed even globally.
So Mr. Minister, welcome. It’s very good to have you. We look forward to the conversation ahead.
FOREIGN MINISTER MOMEN: Thank you. Thank you, Excellency. Thank you for giving me time and this meeting with my colleagues. And also I’m thankful to you for committing 61 million of the vaccines – the highest among all the countries. I think Bangladesh is the number one in terms of receiving the vaccine. And also in addition, the 31 million for the recent economic assistance. And I also thank you because you have declared the genocide in Myanmar, and we’re so happy you did. I hope there will be some repatriation of these persecuted people.
And I’m very pleased that today – the other day we received a letter from President Biden. And it is an excellent letter. It helps what we want to do. It talks about the last 50 years; we have done a remarkable achievement. And U.S. has been always a friend of Bangladesh, during our bad times and our good times. And we look forward for a bright future, and that’s why I’m here.
And also I would like to say that over the last 50 years, Bangladesh really achieved many – a lot of achievements. We were known to be a bottomless basket, but now we have a vibrant economy, a land of opportunity. And the U.S. has been a great partner and friend; over the years you have supported that, and U.S.-Bangladesh will be – your achievement in Bangladesh will be magnified because the U.S. efforts helped us all the way.
But Bangladesh is doing pretty well. The U.S. is our – the biggest trading partner, and also accumulated – the investments in Bangladesh, the U.S. is the largest. But most of the investment has been in the energy sector. Maybe it is time to look beyond that. And I am looking forward for more enhanced and solid – rock-solid relationship with the United States of America.
And I always have some indebtedness to you because when I was homeless, jobless, and stateless, it is USA that provided me a home and a job, and I am thankful for that.
Thank you. Thank you, Excellency.
SECRETARY BLINKEN: Thank you, Mr. Minister. Thank you all.
- The United States Announces New Humanitarian Aid in Central America and Mexico
October 15, 2021Ned Price, Department [Read More…]
- U.S. Asia-Pacific Economic Cooperation (APEC) Travel Card Program FAQs
September 27, 2020Content currently [Read More…]
- Eight Individuals Charged With Conspiring to Act as Illegal Agents of the People’s Republic of China
October 28, 2020A complaint and arrest warrants were unsealed today in federal court in Brooklyn charging eight defendants with conspiring to act in the United States as illegal agents of the People’s Republic of China (PRC). Six defendants also face related charges of conspiring to commit interstate and international stalking. The defendants, allegedly acting at the direction and under the control of PRC government officials, conducted surveillance of and engaged in a campaign to harass, stalk, and coerce certain residents of the United States to return to the PRC as part of a global, concerted, and extralegal repatriation effort known as “Operation Fox Hunt.”
- Two Men Charged in Multi-million Dollar Darknet Drug Distribution Conspiracy
February 12, 2021Two Texas men were charged in a complaint unsealed today for their alleged participation in a drug distribution conspiracy perpetrated over the Darknet.
- Secretary Antony J. Blinken With Roula Khalaf of The Financial Times
May 4, 2021Antony J. Blinken, [Read More…]
- Secretary Pompeo’s Meeting with Slovenian Foreign Minister Logar
December 8, 2020
- Veterans Health Care: Addressing High Risk Concerns for Oversight and Accountability Are Key to Ensuring Quality of Care and Patient Safety
October 27, 2021What GAO Found GAO’s work has identified a range of concerns with the Department of Veterans Affairs’ (VA) oversight and accountability of its health care system, including those related to quality of care and patient safety. Since GAO added VA health care to its High-Risk List in 2015, GAO has made 131 recommendations related to VA’s oversight and accountability, almost half of all GAO’s recommendations for VA health care. Recent examples of quality of care and patient safety recommendations include the following: VA has faced challenges in ensuring that its providers deliver safe and effective care to veterans. In February 2021, GAO identified 227providers that had been removed from VA employment but were potentially providing care in a community care network. GAO recommended that VA take actions to assess and address the situation.VA implemented this recommendation by reviewing and excluding 155providers from participating in VA’s community care networks. In recent years, there have been reports of veterans dying by suicide on VA campuses—in locations such as inpatient settings, parking lots, and on the grounds of VA cemeteries. In September 2020, GAO found that VA lacks accurate information on the number of suicides and comprehensive analyses of the underlying causes. While VA agreed with two of GAO’s recommendations to address these issues, VA still needs to provide documentation of key actions taken by the committee it established to improve its understanding of on-campus suicides. In June 2019, GAO found that VA’s oversight of its regional health care networks was limited. GAO recommended that VA develop a process for assessing the overall performance of its networks to be able to better determine if a network’s performance is positive, if it is functioning poorly, or if it requires remediation. While VA concurred with GAO’s recommendation, VA still needs to provide documentation of the process developed to assess the overall performance of these networks in managing medical centers. Since the last high-risk update in March 2021, VA has taken steps to address some of the oversight and accountability concerns identified by GAO. In May 2021, VA published a revised high-risk action plan for addressing VA health care concerns. However, VA is still in the beginning stages of developing its plan to address root causes such as a fragmented oversight and accountability infrastructure and will need clearly defined metrics to ensure it is effective. Fully addressing oversight and accountability concerns also requires sustained leadership attention as well as leadership stability. However, the Under Secretary for Health position responsible for managing VA health care has not had permanent leadership since January 2017. While VA takes steps to address its needed transformation, it should continue to implement recommendations GAO has made in the oversight and accountability area, given the number of these similar types of recommendations and the need to ensure quality of care and patient safety. Why GAO Did This Study VA operates one of the nation’s largest health care systems. GAO’s work, along with that of VA’s Office of Inspector General and others, has cited longstanding issues with VA’s oversight of its health care system. In 2015, GAO added VA health care to its High-Risk List, in which one broad area of concern was inadequate oversight and accountability. In its latest high-risk update in March 2021, GAO noted continued concern over VA’s ability to ensure the safety and protection of patients and staff, as well as to oversee its programs. This statement describes the oversight and accountability issues GAO’s work has identified related to quality care and patient safety, and the status of VA’s efforts to address its high-risk designation. This statement is based on GAO’s body of work in this area. GAO’s Fiscal Year 2021 Rating for the Inadequate Oversight and Accountability Area For more information, contact Sharon M. Silas at (202) 512-7114 or email@example.com.
- Bahrain Travel Advisory
September 26, 2020
- Sudan Travel Advisory
September 26, 2020
- Biomedical Research: NIH Should Publicly Report More Information about the Licensing of Its Intellectual Property
November 20, 2020Research conducted at Department of Health and Human Services (HHS) labs led to 4,446 U.S. patents owned by the agency covering a range of inventions from 1980 through 2019. During that period, the National Institutes of Health (NIH) had 93 patents—2 percent of the total—that contributed to the successful development of 34 drugs approved by the Food and Drug Administration (FDA) and brought to market, including vaccines and treatments for cancer. These 34 drugs were developed by pharmaceutical companies and were associated with 32 licenses granted to them by NIH. As shown in the figure, these licenses have generated up to $2 billion in royalty revenue for NIH since 1991, when FDA approved the first of these drugs. Three licenses generated more than $100 million each for the agency. Royalties from NIH Licenses of Inventions Associated with FDA-Approved Drugs, 1991 to February 2020 When licensing its inventions, NIH prioritizes the likelihood that the licensee can successfully develop a drug by considering such factors as technical expertise and the ability to raise capital. Consistent with federal interpretation of technology transfer statutory authorities, NIH does not consider the affordability of the resulting drug. NIH provides limited information to the public about its licensing activities. For example, the agency does not report which of its patents are licensed or release metrics that would enable the public to evaluate how licensing affects patient access to resulting drugs. Increasing the transparency of its licensing activities could improve the public’s and policymakers’ understanding of NIH’s management of its intellectual property. HHS monitors for unauthorized use of its inventions (infringement) and has taken steps to protect its rights. HHS relies primarily on inventors at its labs to monitor for potential infringement and generally encourages potential infringers to license the inventions. If cases proceed to litigation, HHS relies on the Department of Justice (DOJ) to protect its rights. Since 2009, HHS has worked with DOJ to defend its intellectual property in several cases in the U.S. and abroad and has referred one case to DOJ for litigation against an alleged infringer. HHS labs conduct research that can contribute to the development of new life-saving drugs. HHS may grant rights to its inventions by licensing the patents to pharmaceutical companies that conduct the additional development activities and testing necessary to bring drugs to market. Public health experts and patients’ rights advocates have raised concerns about the prices of drugs developed with federal support. GAO was asked to review HHS’s management of its intellectual property. This report examines (1) the extent to which HHS-owned intellectual property has contributed to the development of FDA-approved drugs, (2) what is known about the licenses associated with FDA-approved drugs, (3) factors NIH prioritizes when licensing its inventions and information about licensing it makes public, and (4) steps HHS has taken to protect its rights. GAO reviewed relevant laws and agency documents, analyzed patent and licensing data, and interviewed HHS officials, academic experts, industry representatives, and nongovernmental organizations. GAO is making two recommendations, including that NIH provide more information to the public about the licensing of its intellectual property. HHS concurred with GAO’s recommendations. For more information, contact John Neumann, (202) 512-6888, NeumannJ@gao.gov.
- Two Members of Notorious Videogame Piracy Group “Team Xecuter” in Custody
October 2, 2020Two leaders of one of the world’s most notorious videogame piracy groups, Team Xecuter, have been arrested and are in custody facing charges filed in U.S. District Court in Seattle.
- Further Sanctions on Entities Trading in or Transporting Iranian Petrochemicals
March 18, 2020Michael R. Pompeo, [Read More…]
- DOD Financial Management: Air Force Needs to Improve Its System Migration Efforts
February 28, 2022What GAO Found The Air Force relies on its financial management systems to help manage department operations and support core accounting activities, such as maintaining financial records and making payments. Its environment is complex and consists of multiple systems that are not fully integrated, preventing Air Force management from obtaining timely, accurate, and reliable information on the results of its business operations. To address these issues, the Air Force has been migrating from its legacy, or aging, financial management systems to more modern target systems. One such key target is the Defense Enterprise Accounting and Management System (DEAMS), which is to be the Air Force’s core accounting and finance system. DEAMS has been deployed incrementally to Air Force users since 2005, and the Air Force plans to expand its use in the future (see figure). Air Force’s Defense Enterprise Accounting and Management System (DEAMS) Timeline The Air Force has not followed leading practices, such as developing a migration plan to guide its transition from the existing legacy system to DEAMS. Instead, the Air Force decided to pursue a dual processing policy in which the legacy and target systems would both continue to operate for at least the next 10 years. The continued use of the legacy system means that resolution of its deficiencies would be delayed for many years. Further, associated internal control weaknesses would also persist. Auditors have identified numerous issues related to the Air Force’s broader financial management systems, including DEAMS. For fiscal year 2020, auditors reported deficiencies including nonintegrated Air Force financial systems, an insufficient financial reporting process, and a lack of controls in the design of information systems. While the Air Force has some efforts under way to address financial management system–related deficiencies, it does not have a comprehensive strategy encompassing the entirety of its financial management systems modernization efforts. Without such a comprehensive financial management system strategy, it will be more difficult for the Air Force to report accurate and reliable financial information. Moreover, the Air Force will continue to face difficulties developing and fully implementing Air Force–wide corrective action plans to address the system-related issues that auditors identified. These issues have led to the Air Force not being able to provide sufficient, appropriate audit evidence to support the reported amounts in its financial statements. Why GAO Did This Study The Air Force is currently modernizing and migrating its financial management systems as part of a broader effort to improve financial management operations and prepare auditable financial statements. Successful system migration is key to the Air Force addressing weaknesses that financial statement auditors have identified. The Government Management Reform Act of 1994 includes a provision for GAO to audit the U.S. government’s consolidated financial statements. This report examines the extent to which the Air Force is (1) following leading practices for its financial management system migration and (2) planning to address the financial management system–related issues that auditors identified. GAO reviewed guidance on system migration leading practices; observed DEAMS program operations; reviewed documentation related to the Air Force’s migration efforts and strategy, financial statement audit results, and efforts to resolve system deficiencies; and interviewed cognizant officials.
- Panama child pornography investigation leads to sentencing of young man
In Justice NewsAugust 30, 2021An 18-year-old [Read More…]
- Cameroon Travel Advisory
September 26, 2020
- Man Arrested in Connection with Alleged Role in Twitter Hack
July 21, 2021A citizen of the United Kingdom was arrested today in Estepona, Spain, by Spanish National Police pursuant to a U.S. request for his arrest on multiple charges in connection with the July 2020 hack of Twitter that resulted in the compromise of over 130 Twitter accounts, including those belonging to politicians, celebrities and companies.
- The Quad Welcome UNITAMS Announcement on Facilitating Discussions to Resolve Sudan’s Political Crisis
January 8, 2022
- Secretary Antony J. Blinken at a Virtual Meeting with Japanese Women Entrepreneurs
March 16, 2021Antony J. Blinken, [Read More…]
- Deputy Secretary Biegun Remarks at the U.S.-India Strategic Partnership Forum
September 26, 2020Stephen Biegun, Deputy [Read More…]
- Special Presidential Envoy for Arms Control Billingslea to Address the Conference on Disarmament
January 18, 2021